HKD 7.83
(-6.23%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 2.11 Billion CNY | -15.03% |
2022 | 2.48 Billion CNY | -6.22% |
2021 | 2.65 Billion CNY | 298.6% |
2020 | 665.97 Million CNY | 107.96% |
2019 | 320.23 Million CNY | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q2 | 2.25 Billion CNY | 0.0% |
2024 Q1 | 2.25 Billion CNY | 6.78% |
2023 FY | 2.11 Billion CNY | -15.03% |
2023 Q2 | 2.34 Billion CNY | 0.0% |
2023 Q1 | 2.34 Billion CNY | -5.69% |
2023 Q4 | 2.11 Billion CNY | 0.0% |
2023 Q3 | 2.11 Billion CNY | -9.9% |
2022 Q2 | 2.6 Billion CNY | 0.0% |
2022 Q1 | 2.6 Billion CNY | -2.05% |
2022 FY | 2.48 Billion CNY | -6.22% |
2022 Q4 | 2.48 Billion CNY | 0.0% |
2022 Q3 | 2.48 Billion CNY | -4.25% |
2021 Q2 | - CNY | -100.0% |
2021 FY | 2.65 Billion CNY | 298.6% |
2021 Q1 | 1.4 Billion CNY | 0.0% |
2021 Q4 | 2.65 Billion CNY | 0.0% |
2021 Q3 | 2.65 Billion CNY | 0.0% |
2020 FY | 665.97 Million CNY | 107.96% |
2020 Q1 | - CNY | 0.0% |
2019 FY | 320.23 Million CNY | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
Uni-Bio Science Group Limited | 409.99 Million HKD | -415.957% |
CK Life Sciences Int'l., (Holdings) Inc. | 11.24 Billion HKD | 81.192% |